Mobile Menu

Search Results

Search results for: Computational biology

Single-Cell for Cancer Biology ONLINE

Single-Cell sequencing has already become a staple methodology for medical research. Much of this advancement has happened within, and is directly relevant to cancer biology. Hence, we are really excited to launch our new webinar series – Single-Cell for Cancer Biology ONLINE – to directly explore the latest impact that single-cell methodologies are having on cancer research.

Updated computational tools for spatial transcriptomics analysis

Spatial molecular analysis is not new. However, many subcellular, high-multiplex and multi-omics spatial methods have only emerged over the past […]

Single Cell Biology ONLINE

Our latest webinar series: Single Cell Biology ONLINE will bring you granular insights from the most complex, heterogeneous tissues and […]

New computational tool maps development of immune cells

Researchers from the Wellcome Sanger Institute have developed a computational pipeline for mapping immune cell development. The tool, described in […]

Spatial Biology ONLINE

How cells interact with other cells and their environment has proven pivotal to our understanding of, and ability to target, […]

Spatial Biology ONLINE – September 2022

Join us for our latest webinar series – Spatial Biology ONLINE -where we’ll be discussing advances in spatial analysis and […]

Genome Giants – Leroy Hood, Co-founder and Professor, Institute for Systems Biology

Leroy Hood is a pioneer of systems biology and Professor and Co-founder of the Institute for Systems Biology, Seattle. He […]

Computational program deciphers any genetic code

A recent paper has described a new computer program that can read the genome sequence of any organism and then […]

The Festival of Genomics & Biodata Boston 2024 

Are you ready? The Festival of Genomics & Biodata is heading back to Boston!  After a triumphant return to the […]

Genomics in Drug Discovery ONLINE

On average, it takes 10.5 years for a Phase I drug to progress to regulatory approval and only ~8% of […]